From May 9, 2024 to June 30, 2024, the company has repurchased 7,117,700 shares, representing 1.96% for ¥11,361.01 million. With this, the company has completed the repurchase of 7,117,700 shares, representing 1.96% for ¥11,361.01 million under the buyback announced on May 9, 2024.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,678 JPY | -0.83% |
|
+2.04% | +19.40% |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+19.40% | 3.72B | |
+56.89% | 823B | |
+39.52% | 627B | |
-6.55% | 353B | |
+15.99% | 320B | |
+7.92% | 295B | |
+13.74% | 239B | |
+13.83% | 220B | |
-0.49% | 219B | |
+7.94% | 167B |
- Stock Market
- Equities
- 4536 Stock
- News Santen Pharmaceutical Co., Ltd.
- Tranche Update on Santen Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on May 9, 2024.